Paper

Response to the letter to the editor by Pontoriero et al. regarding the article “Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer – PORTEC-4a an international randomised phase 3 trial by Van den Heerik et al.”

Radiotherapy and Oncology · 2026 · Anne Sophie V M van den Heerik, Nanda Horeweg, Carien L Creutzberg et al.